Psoriatic Arthritis
News
Psoriatic arthritis eludes early diagnosis
Patients with psoriasis have an increased risk for psoriatic arthritis, but diagnosing its onset early poses challenges.
Conference Coverage
Guselkumab tops secukinumab over 48 weeks for plaque psoriasis
CAYMAN ISLANDS – In both groups, the PASI 90 increased similarly in the first month, but was consistently higher in the guselkumab group at week...
Conference Coverage
Comorbidities may cut effectiveness of psoriasis biologics
PARIS – In the PSO-BIO-REAL study, PASI 100 rate dropped as the number of comorbidities rose.
Conference Coverage
Brodalumab raced past ustekinumab to PASI 100
PARIS – Pooled analysis of phase 3 trials spotlights one clinical setting where brodalumab is particularly advantageous.
Conference Coverage
Longterm maintenance of PASI 75 responses observed with tildrakizumab
PARIS – More than 90% of PASI 75 responders to tildrakizumab at 6 months maintained at least a PASI 75 response at 148 weeks.
Conference Coverage
CONDOR trial: Most psoriasis patients can be downshifted to reduced-dose biologics
PARIS – Results of the first-ever randomized trial of biologic dose reduction in well-controlled psoriasis patients are reported.
News
Back pain criteria perform well in patients with active axial psoriatic arthritis
The tool performed suboptimally overall, but had good sensitivity and specificity in patients with active symptoms.
Latest News
Positive results reported for ixekizumab versus adalimumab in PsA
Lilly described top-line results for the SPIRIT-H2H trial.
Conference Coverage
Natural killer cells implicated in psoriatic arthritis
CHICAGO – Translational study brings a genetic test for psoriatic arthritis one step closer.
News
Algorithm proposes approach for managing TNF inhibitor–induced psoriasis